Related Experiment Video

Updated: May 30, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma

B Amend1, J Hennenlotter, M Scharpf

  • 1Department of Urology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany.

World Journal of Urology
|August 9, 2011
PubMed
Abstract

Insights

Renal oncocytomas show significantly lower levels of PTEN, p-Akt, and p27(Kip1) compared to clear cell renal cell carcinoma (ccRCC). These findings offer insights into the molecular mechanisms of renal tumor dedifferentiation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Renal oncocytomas are benign tumors with poorly understood molecular mechanisms.
  • The PKB/Akt pathway is implicated in malignant tumor progression, but its role in oncocytomas is unclear.
  • Data on Akt signaling parameters in oncocytomas are scarce.

Purpose of the Study:

  • To investigate alterations in PTEN, phosphorylated Akt (p-Akt), and p27(Kip1) in renal oncocytomas.
  • To compare these parameters between oncocytomas, clear cell renal cell carcinoma (ccRCC), and benign renal tissue.
  • To enhance understanding of renal tumor dedifferentiation and the PKB/Akt signaling axis.

Main Methods:

  • Tissue microarray analysis of 15 oncocytomas, 18 ccRCCs, and corresponding benign tissues.
  • Immunohistochemistry was used to determine the expression levels of PTEN, p-Akt, and p27(Kip1).
  • Statistical analyses included One-way ANOVA with Tukey-Kramer post hoc tests and linear regression for parameter interactions.

Main Results:

  • PTEN and p27(Kip1) expression was significantly lower in oncocytomas compared to both benign tissue and ccRCC (p < 0.001).
  • p-Akt expression was significantly lower in oncocytomas compared to ccRCC (p < 0.05).
  • All three investigated proteins showed significantly different expression levels across the groups.

Conclusions:

  • PTEN and p27(Kip1) expression levels are markedly reduced in oncocytomas relative to ccRCC.
  • The observed low expression of PTEN and p27(Kip1) in oncocytomas may be associated with benign tumor characteristics.
  • These findings contribute to understanding the PKB/Akt signaling pathway in renal tumors and tumor dedifferentiation.

More Related Videos

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses09:31

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses

Published on: March 30, 2015

A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...